Popular diabetes drugs not linked to thyroid cancer risk, study finds

Drugs known as GLP-1 analogs have become increasingly popular to treat diabetes and obesity, but there have been concerns that they might increase the risk of thyroid cancer.

Most Doc Groups Unhappy With Proposed Congressional Budget Deal

A deal agreed to by congressional negotiators over the weekend would increase Medicare physician pay by 1.68%, but doctors’ groups expressed concern that it wouldn’t

March 5, 2024

Stopping Tirzepatide Led to Weight Gain, Trial Shows

After discontinuing the weight-management injectable tirzepatide (Zepbound), most patients had a hard time keeping the weight off during the phase III SURMOUNT-4 trial. People on

December 14, 2023

Study: A new paradigm for the fabrication of metallic bionic tissues

In a new study published on July 27 in Matter, a research group led by Prof. LIU Jing at the Technical Institute of Physics and

July 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.